Molecular advances in pretargeting radioimunotherapy with bispecific antibodies. - Wikidata - awgldk - TriplyDB

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

http://www.wikidata.org/entity/Q35024302

about

Affinity and avidity in antibody-based tumor targeting Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry A pretargeting system for tumor PET imaging and radioimmunotherapy Modern Technologies for Creating Synthetic Antibodies for Clinical application.Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results.A modular IgG-scFv bispecific antibody topology.Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.Necrosis targeted combinational theragnostic approach using radioiodinated Sennidin A in rodent tumor models.Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imaging Pretargeted radioimmunotherapy for hematologic and other malignancies The potential and hurdles of targeted alpha therapy - clinical trials and beyond.Evaluation of the therapeutic efficacy of sequential therapy involving percutaneous microwave ablation in combination with 131I-hypericin using the VX2 rabbit breast solid tumor model Bioorthogonal Oxime Ligation Mediated In Vivo Cancer Targeting.Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models.Novel DNA Polymer for Amplification Pretargeting.An improved method for covalently conjugating morpholino oligomers to antitumor antibodies Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.A semiempirical model of tumor pretargeting.Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.Pretargeted molecular imaging and radioimmunotherapy.Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.Structural features of interfacial tyrosine residue in ROBO1 fibronectin domain-antibody complex: Crystallographic, thermodynamic, and molecular dynamic analyses.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.Evaluation of a Pretargeting Strategy for Molecular Imaging of the Prostate Stem Cell Antigen with a Single Chain Antibody.

P2860

Q24613552-F140FC68-2942-43A1-8F60-DD52070B5F95 Q27026010-6CDFE612-5A83-4239-8223-86B08FF2CCA4 Q28087820-A730ADF6-31A6-4278-86C4-F97B8AD6D4E8 Q30467308-17A34DEA-0864-4775-81DC-6DC80C266FF2 Q33409137-7688E4C5-CA38-4D0A-96C1-F622C90D59AD Q33519465-A11335FF-C731-424A-91AB-C4154406E1CA Q33780787-427FE55A-C85B-4E46-804F-FD19D261B90C Q33917524-46C74927-7525-42F3-96ED-45C6594D8A96 Q33921086-66F4FFD4-A9DF-4894-96C3-B7B97C2D6840 Q34113941-00AF9A5D-F346-49A0-B4C0-4A45E10F7AC7 Q34399879-E61FF5EA-53AD-4170-B7D5-56D02757AD30 Q35208876-42249A2A-73BF-40B8-BF0B-E0B15F653976 Q35801347-B181B493-8B89-470A-9490-17D67BBF3034 Q35819169-4B3D002A-F9DF-47E1-892B-C9C2EA9205C3 Q35828820-6386EFB7-842F-45E7-A707-B30292B78D5D Q35987317-AC7C19E4-ABFA-4525-BEDE-26452A7DB0AB Q36059787-6A84A163-2420-4A75-9D84-D55CD53726EB Q36865885-E78B0768-AD45-4D05-8200-89D7EAD2112B Q37207310-E36FD57C-A06E-417A-83EF-C22791AFDFA8 Q37288717-01E026FD-59BF-4562-AED8-8DD04DB8BACF Q37588304-71B570FF-1D6E-4069-B3EA-4DF271966F6F Q38022016-EB5F9189-8FC3-4413-9CDB-B94D5CB56E00 Q39958380-4F7745ED-E26E-46FF-818D-2A31F3F722DE Q41945566-65231303-F9DB-42DB-827C-65DA792456FB Q54257268-F01541EA-5836-4466-B622-6AD37A8960E4 Q55246887-FA76D9EE-0498-4CBC-AA49-53BB030559C7

P2860

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

http://www.wikidata.org/entity/Q35024302

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

@ast

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

@en

type

label

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

@ast

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

@en

prefLabel

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

@ast

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

@en

P1433

Q35024302-A4C52E30-C81D-45D4-B63A-C2649612C055

P1476

Q35024302-90C7883F-421F-4A02-B200-C30B137A06FB

P2093

Q35024302-1DE0D693-90A0-4CD8-B569-A946EAA4FC24

Q35024302-45D21D85-7640-4C79-8010-0293EEC947E0

Q35024302-47BA2B13-603E-48C2-B129-13E0DEDECD07

Q35024302-6B6FE287-0635-4F68-B619-BA0EB6D34217

Q35024302-9E4361C0-4EF2-413D-AA88-C7DFB0660CCB

Q35024302-AA02A377-4999-4A1F-93DC-25873AF281EE

Q35024302-AF1980A8-CC4C-4023-97C6-9778B59A9D78

Q35024302-C216463F-FB6D-49DE-99A6-224814466707

Q35024302-D2BEACD6-D7E0-4474-97B5-218FDCCC4155

P304

Q35024302-782FF22D-8C55-4E07-B057-B36547F5D514

P31

Q35024302-2E190D5A-7C9E-4E80-A8BC-3D2DFAFE1BA7

P433

Q35024302-4C41F3E8-CA50-4820-8EFD-A45A1E5CF95A

P478

Q35024302-787FF7FA-71EA-4DB4-AF16-E80C72A6A225

P577

Q35024302-DD132325-B865-4C76-82FE-5277AA69C04A

P698

Q35024302-8BCE7266-01EE-4016-ACB4-2A7D26074FD5

P921

Q35024302-5EFC4483-1623-4651-A43C-E8512FFD10D7

P1433

Molecular Cancer Therapeutics

P1476

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies

@en

P2093

Chien-Hsing Chang

http://www.w3.org/2001/XMLSchema#string

David M Goldenberg

http://www.w3.org/2001/XMLSchema#string

Edmund A Rossi

http://www.w3.org/2001/XMLSchema#string

Habibe Karacay

http://www.w3.org/2001/XMLSchema#string

Hans J Hansen

http://www.w3.org/2001/XMLSchema#string

Jacques Barbet

http://www.w3.org/2001/XMLSchema#string

Jean-François Chatal

http://www.w3.org/2001/XMLSchema#string

Robert M Sharkey

http://www.w3.org/2001/XMLSchema#string

William McBride

http://www.w3.org/2001/XMLSchema#string

P304

553-563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12479274

http://www.w3.org/2001/XMLSchema#string

P921